Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Table 2 Demographics of study participants with a history of VVC/RVVC

Race	Caucasian	77.7% (202)^b
	African American	14.2% (37)
	Asian	8.1% (21)
	Native American	0.0% (0)
	Native Hawaiian/Pacific Islander	0.0% (0)
Ethnic category	Hispanic or Latino	8.2% (20)
Ethnic category	Not Hispanic or Latino	91.8% (224)
Age	18–25	13.6% (36)
	26–40	49.4% (131)
	41–55	22.3% (59)
	> 55	14.7% (39)
Lifetime history of infection	No history	22.5% (64)
Lifetime history of infection	≥1	77.5% (220)
Annual frequency of infection	≤3	65.4% (132)
Annual frequency of infection	> 3 (RVVC)^a	34.6% (70)

^aRVVC, recurrent vulvovaginal candidiasis defined as 4 or more acute episodes in a 12-month period
^bValues in parentheses indicate the number of respondents who selected each response choice

ISSN: 1472-6874